+Open data
-Basic information
Entry | Database: PDB / ID: 9fa9 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Coxsackievirus A9 bound with compound 16 (CL298) | ||||||||||||
Components |
| ||||||||||||
Keywords | VIRUS / Antiviral / capsid stabilizer / hydrophobic pocket / cryoEM | ||||||||||||
Function / homology | Function and homology information symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of RIG-I activity / picornain 2A / symbiont-mediated suppression of host mRNA export from nucleus / symbiont genome entry into host cell via pore formation in plasma membrane / picornain 3C / T=pseudo3 icosahedral viral capsid / host cell cytoplasmic vesicle membrane / endocytosis involved in viral entry into host cell / nucleoside-triphosphate phosphatase / channel activity ...symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of RIG-I activity / picornain 2A / symbiont-mediated suppression of host mRNA export from nucleus / symbiont genome entry into host cell via pore formation in plasma membrane / picornain 3C / T=pseudo3 icosahedral viral capsid / host cell cytoplasmic vesicle membrane / endocytosis involved in viral entry into host cell / nucleoside-triphosphate phosphatase / channel activity / monoatomic ion transmembrane transport / DNA replication / RNA helicase activity / induction by virus of host autophagy / RNA-directed RNA polymerase / viral RNA genome replication / cysteine-type endopeptidase activity / RNA-dependent RNA polymerase activity / virus-mediated perturbation of host defense response / DNA-templated transcription / host cell nucleus / virion attachment to host cell / structural molecule activity / ATP hydrolysis activity / proteolysis / RNA binding / ATP binding / membrane / metal ion binding Similarity search - Function | ||||||||||||
Biological species | Human coxsackievirus A9 | ||||||||||||
Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.75 Å | ||||||||||||
Authors | Plavec, Z. / Butcher, S.J. / Mitchell, C. / Buckner, C. | ||||||||||||
Funding support | Finland, 3items
| ||||||||||||
Citation | Journal: J Med Chem / Year: 2024 Title: SAR Analysis of Novel Coxsackie virus A9 Capsid Binders. Authors: Chiara Tammaro / Zlatka Plavec / Laura Myllymäki / Cristopher Mitchell / Sara Consalvi / Mariangela Biava / Alessia Ciogli / Aušra Domanska / Valtteri Leppilampi / Cienna Buckner / Simone ...Authors: Chiara Tammaro / Zlatka Plavec / Laura Myllymäki / Cristopher Mitchell / Sara Consalvi / Mariangela Biava / Alessia Ciogli / Aušra Domanska / Valtteri Leppilampi / Cienna Buckner / Simone Manetto / Pietro Sciò / Antonio Coluccia / Mira Laajala / Giulio M Dondio / Chiara Bigogno / Varpu Marjomäki / Sarah J Butcher / Giovanna Poce / Abstract: Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the (EV-B), namely Coxsackievirus A9 (CVA9), using ...Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination from cryogenic electron microscopy and molecular modeling, to determine the structure activity relationships for a promising class of novel -phenylbenzylamines. Of the new 29 compounds synthesized, 10 had half maximal effective concentration (EC) values between 0.64-10.46 μM, and of these, 7 had 50% cytotoxicity concentration (CC) values higher than 200 μM. In addition, this new series of compounds showed promising physicochemical properties and act through capsid stabilization, preventing capsid expansion and subsequent release of the genome. #1: Journal: Protein Sci / Year: 2018 Title: UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Authors: Thomas D Goddard / Conrad C Huang / Elaine C Meng / Eric F Pettersen / Gregory S Couch / John H Morris / Thomas E Ferrin / Abstract: UCSF ChimeraX is next-generation software for the visualization and analysis of molecular structures, density maps, 3D microscopy, and associated data. It addresses challenges in the size, scope, and ...UCSF ChimeraX is next-generation software for the visualization and analysis of molecular structures, density maps, 3D microscopy, and associated data. It addresses challenges in the size, scope, and disparate types of data attendant with cutting-edge experimental methods, while providing advanced options for high-quality rendering (interactive ambient occlusion, reliable molecular surface calculations, etc.) and professional approaches to software design and distribution. This article highlights some specific advances in the areas of visualization and usability, performance, and extensibility. ChimeraX is free for noncommercial use and is available from http://www.rbvi.ucsf.edu/chimerax/ for Windows, Mac, and Linux. | ||||||||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 9fa9.cif.gz | 275.3 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb9fa9.ent.gz | Display | PDB format | |
PDBx/mmJSON format | 9fa9.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 9fa9_validation.pdf.gz | 1.6 MB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 9fa9_full_validation.pdf.gz | 1.6 MB | Display | |
Data in XML | 9fa9_validation.xml.gz | 44.7 KB | Display | |
Data in CIF | 9fa9_validation.cif.gz | 65.4 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/fa/9fa9 ftp://data.pdbj.org/pub/pdb/validation_reports/fa/9fa9 | HTTPS FTP |
-Related structure data
Related structure data | 50269MC 8s7jC 9exiC 9fczC 9fgnC 9fo2C 9fo5C 9fp5C M: map data used to model this data C: citing same article (ref.) |
---|---|
Similar structure data | Similarity search - Function & homologyF&H Search |
-Links
-Assembly
Deposited unit |
|
---|---|
1 |
| x 60
-Components
#1: Protein | Mass: 32053.998 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) Human coxsackievirus A9 (strain Griggs) / Cell line: GMK / Strain: Griggs / Tissue: kidney / References: UniProt: P21404 |
---|---|
#2: Protein | Mass: 28885.518 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) Human coxsackievirus A9 (strain Griggs) / Cell line: GMK / Strain: Griggs / Tissue: kidney / References: UniProt: P21404 |
#3: Protein | Mass: 26335.072 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) Human coxsackievirus A9 (strain Griggs) / Cell line: GMK / Strain: Griggs / Tissue: kidney / References: UniProt: P21404 |
#4: Protein | Mass: 7352.039 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) Human coxsackievirus A9 (strain Griggs) / Cell line: GMK / Strain: Griggs / Tissue: kidney / References: UniProt: P21404 |
#5: Chemical | ChemComp-A1IBS / ~{ Mass: 313.412 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C19H24FN3 / Feature type: SUBJECT OF INVESTIGATION |
Has ligand of interest | Y |
Has protein modification | N |
-Experimental details
-Experiment
Experiment | Method: ELECTRON MICROSCOPY |
---|---|
EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-Sample preparation
Component | Name: Coxsackievirus A9 / Type: VIRUS Details: Coxsackievirus A9 was propagated on green monkey kidney cells and purified on a sucrose gradient. Entity ID: #1-#4 / Source: NATURAL |
---|---|
Molecular weight | Value: 8 MDa / Experimental value: NO |
Source (natural) | Organism: Coxsackievirus A9 / Strain: Griggs |
Details of virus | Empty: NO / Enveloped: NO / Isolate: STRAIN / Type: VIRION |
Natural host | Organism: Homo sapiens |
Virus shell | Name: icosahedral capsid / Diameter: 300 nm / Triangulation number (T number): 1 |
Buffer solution | pH: 7.2 |
Specimen | Conc.: 0.4 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: Compound 16 (CL298) was solubilized in DMSO and diluted to the final concentration in PBS + 2 mM MgCl2. Purified Coxsackievirus A9 was incubated with compound 16 (CL298) for 1h at 37C after ...Details: Compound 16 (CL298) was solubilized in DMSO and diluted to the final concentration in PBS + 2 mM MgCl2. Purified Coxsackievirus A9 was incubated with compound 16 (CL298) for 1h at 37C after which the sample was vitrified on a semi-automatic plunger Leica EM GP on copper Quantifoil R1.2/1.3 grids with thin carbon film and 300 mesh. This sample was monodisperse. |
Specimen support | Grid material: COPPER / Grid mesh size: 300 divisions/in. / Grid type: Quantifoil R1.2/1.3 |
Vitrification | Instrument: LEICA EM GP / Cryogen name: ETHANE / Humidity: 85 % / Chamber temperature: 295.15 K Details: Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s. |
-Electron microscopy imaging
Experimental equipment | Model: Talos Arctica / Image courtesy: FEI Company |
---|---|
Microscopy | Model: FEI TALOS ARCTICA |
Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 200 kV / Illumination mode: FLOOD BEAM |
Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 150000 X / Nominal defocus max: 3000 nm / Nominal defocus min: 500 nm / Calibrated defocus min: 700 nm / Calibrated defocus max: 3000 nm |
Specimen holder | Cryogen: NITROGEN / Temperature (max): 103.15 K / Temperature (min): 93.15 K |
Image recording | Average exposure time: 1 sec. / Electron dose: 40 e/Å2 / Detector mode: COUNTING / Film or detector model: FEI FALCON III (4k x 4k) / Num. of grids imaged: 1 / Num. of real images: 530 |
Image scans | Width: 1496 / Height: 1496 |
-Processing
EM software |
| |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | |||||||||||||||||||||||||||||||||||||||||||||
Particle selection | Num. of particles selected: 19317 | |||||||||||||||||||||||||||||||||||||||||||||
3D reconstruction | Resolution: 2.75 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 15691 / Symmetry type: POINT | |||||||||||||||||||||||||||||||||||||||||||||
Atomic model building | B value: 119.5 | |||||||||||||||||||||||||||||||||||||||||||||
Atomic model building | PDB-ID: 8at5 Accession code: 8at5 / Source name: PDB / Type: experimental model |